Clinical Trial

Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis

Name: Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis — clinical trial record (NCT07695701)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ASCEND-ATTR

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The study aims to evaluate the effect of acoramidis on cardiac functional and structural improvement in participants with ATTR-CM.

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-30

Trial Details

NCT Number	NCT07695701
Lead Sponsor	Eidos Therapeutics, a BridgeBio company
Conditions	Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM), Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis
Enrollment	150 participants
Start Date	2026-07
Primary Completion	2030-08 (estimated)
Study Completion	2030-11 (estimated)
Updated on ClinicalTrials.gov	2026-07-29